Login / Signup

Authors' Reply to Mazza et al.: "Fluvoxamine for the Early Treatment of SARS‑CoV‑2 Infection: A Review of Current Evidence".

Eric J LenzeAngela M ReiersenShelley N Facente
Published in: Drugs (2022)
Keyphrases
  • respiratory syndrome coronavirus
  • combination therapy
  • sars cov
  • coronavirus disease